HAE
Haemonetics Corp
Price:  
64.09 
USD
Volume:  
1,246,583.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HAE Intrinsic Value

13.60 %
Upside

As of 2025-02-19, the Intrinsic Value of Haemonetics Corp (HAE) is 72.83 USD. This HAE valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 64.09 USD, the upside of Haemonetics Corp is 13.60%.

The range of the Intrinsic Value is 47.12 - 137.02 USD

64.09 USD
Stock Price
72.83 USD
Intrinsic Value
Intrinsic Value Details

HAE Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 47.12 - 137.02 72.83 13.6%
DCF (Growth 10y) 74.38 - 195.28 109.19 70.4%
DCF (EBITDA 5y) 60.41 - 109.99 75.92 18.5%
DCF (EBITDA 10y) 84.53 - 152.90 106.85 66.7%
Fair Value 61.61 - 61.61 61.61 -3.87%
P/E 61.24 - 87.93 74.66 16.5%
EV/EBITDA 42.83 - 80.30 59.46 -7.2%
EPV 17.17 - 28.09 22.63 -64.7%
DDM - Stable 18.88 - 53.56 36.22 -43.5%
DDM - Multi 45.08 - 101.18 62.57 -2.4%

HAE Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 3,219.88
Beta 1.42
Outstanding shares (mil) 50.24
Enterprise Value (mil) 4,145.56
Market risk premium 4.60%
Cost of Equity 10.64%
Cost of Debt 4.28%
WACC 9.18%